Feeds:
Posts
Comments

Posts Tagged ‘7 summits climb for Alzheimer’s’

Update On Our Good Friend  and Advocate Alan Arnette and The 7 Summits Climb For Alzheimer’s

Alan Arnette reached the summit of Kilimanjaro – the highest peak in Africa – just this morning! He notes that his 6th of The 7 Summits Climb For Alzheimer’s is particularly special during this World Alzheimer’s Month and he encourages listeners to learn about the differences between Alzheimer’s and normal aging.

Alan provides an update that it will take the team about four hours to get back down to high camp and another four hours to get to 10,000 ft camp.

You can listen to the full audio dispatch here.

Read Full Post »

 

Alzheimer’s Association Salutes Advocate and Mountaineer Now Climbing Everest

Part of The 7 Summits Climb for Alzheimer’s  

NEW YORK (May 10, 2011) – Pfizer Inc., together with its collaborator on the Alzheimer’s Immunotherapy Program, Janssen Alzheimer Immunotherapy, is pleased to announce the Alzheimer’s Association™,  the world’s leading voluntary health organization in Alzheimer’s care, support and research, as a new beneficiary of The 7 Summits Climb for Alzheimer’s: Memories are Everything campaign. Through this campaign, mountaineer and Alzheimer’s disease advocate Alan Arnette is seeking to climb the 7 Summits, the highest peak on each continent, to raise awareness of the enormous financial and personal burden Alzheimer’s places on people with the disease, their family caregivers and society, as well as to raise $1 million for the Alzheimer’s community. Alan’s highest and most challenging climb of the 7 Summits, Mt. Everest, is now underway.

Everest, the tallest peak in the world, is Alan’s third climb of the 7 summits, after he successfully summitted Vinson Massif in Antarctica and Aconcagua in Argentina. Alan is attempting to reach the peaks of all 7 summits in one year, and if successful, will join just a small group of climbers who have accomplished this major feat. He will face challenges climbing Everest, including altitude sickness, hidden crevasses and the Khumbu Icefall – a slow moving river of unsteady ice with falling ice towers. Alan’s inspiration for his challenging climbs is his mother, Ida Arnette, whom he cared for as she suffered from Alzheimer’s, a devastating disease for which there’s no cure, and ultimately passed away in 2009. The funds he raises will go directly to three leading nonprofit organizations: the Alzheimer’s Association, the Cure Alzheimer’s Fund™ and the National Family Caregivers Association (NFCA).

“We support Alan’s steadfast commitment to climbing the highest mountain in the world to rally support around Alzheimer’s disease,” said Gregory Rippon, MD, MS, Senior Director, Medical Affairs, Pfizer, on behalf of the Alzheimer’s Immunotherapy Program. “We commend his year-long effort to bring hope and inspiration to the Alzheimer’s community.”

“The Alzheimer’s Association sincerely appreciates Alan’s support and dedications in raising awareness and supporting our efforts to create a world without Alzheimer’s. Alan knows firsthand the devastating impact Alzheimer’s has on individuals and their loved ones and represents a generation of baby boomers, too many of whom will spend their retirement years with Alzheimer’s or caring for someone who has it,” said Angela Geiger, Chief Strategy Officer of the Alzheimer’s Association. “It is our hope that Alan’s dedication will inspire people to get involved by advocating, donating and educating others about Alzheimer’s disease.”

Alzheimer’s touches the lives of millions of Americans, and according to the Alzheimer’s Association, 5.4 million Americans are living with Alzheimer’s and require that nearly 15 million people to provide care and support. The Alzheimer’s Immunotherapy Program of Janssen Alzheimer Immunotherapy and Pfizer Inc. is funding Alan’s climbs so that all money he raises from donations will go directly to the organizations he has selected. You can follow Alan’s progress on Everest or make a donation to one of his chosen nonprofits by visiting www.Climb4AD.com or www.Facebook.com/Climb4AD.

Check some of Alan’s videos on facebook

Alzheimer’s Immunotherapy Program

The Alzheimer’s Immunotherapy Program of Janssen Alzheimer Immunotherapy and Pfizer Inc. is an equal collaboration committed to researching and developing selective products for the treatment and/or prevention of neurodegenerative conditions, including Alzheimer’s disease.

The Alzheimer’s Immunotherapy Program believes that it is possible to reduce the burden of disease through early intervention in the illness.  It is dedicated to delivering comprehensive and integrated solutions that help address the needs of people impacted by Alzheimer’s disease.

Its research focuses on the beta amyloid hypothesis.  Scientific evidence supports the idea that preventing the accumulation and/or promoting the removal of beta-amyloid may have the potential to slow the progression of Alzheimer’s disease and help preserve function in people with the disease.  This theory is being tested in clinical trials.

Pfizer Inc.: Working together for a healthier world™

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life.  We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals.  Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products.  Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.  Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.  To learn more about our commitments, please visit us at www.pfizer.com.

 

Alzheimer’s Association

The Alzheimer’s Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s®. For more information, visit www.alz.org.

 

National Family Caregivers Association

National Family Caregivers Association (NFCA) envisions an America in which family caregivers lead full and productive lives, free from depression, pain, isolation, and financial distress.  NFCA provides family caregivers support, education, and a public voice.

Cure Alzheimer’s Fund

The Cure Alzheimer’s Fund is a non-profit public charity established to provide funding for targeted research into the causes of Alzheimer’s disease.  The Cure Alzheimer’s Fund exists exclusively to fund targeted research to hasten the slowing, stopping or reversing of Alzheimer’s disease

Read Full Post »

Check out Alan Arnette’s Audio as He Climbs Mt Everest

Click Here for the Audio

Check out Alan’s amazing website for detailed information, photos, and video of his mission to raise one million dollars for Alzheimer’s disease.  The site is absolutely fascinating!

And don’t forget his Blog.  Alan has wonderful stories about his journey.

Below is a video with Alan and his Mother who has Alzheimer’s .  She is just a doll!

7 Summit’s Campaign Backgrounder

The 7 Summits Climb for Alzheimer’s: Memories are Everything is a year-long challenge by mountain climber and Alzheimer’s disease advocate Alan Arnette to scale the 7 summits, the highest peak on each continent. Alan climbs in memory of his mother, who passed away in 2009 from Alzheimer’s disease.

Alzheimer’s disease is the 6th leading cause of death in the United States, with another person newly diagnosed every 70 seconds. It is estimated to affect more than 5 million people in the United States and more than 25 million people worldwide. That’s why Alan chose to climb the 7 highest summits of the world to raise awareness of the growing prevalence of Alzheimer’s disease in our aging population and the enormous financial and personal burden it places on people with the disease, their caregivers and society. Alan is also striving to raise $1 million to advance Alzheimer’s research and provide support for family caregivers.

The Mountainous Burden of the Disease

 

What do mountain climbing and Alzheimer’s disease have in common? The mental and physical demands of scaling seemingly insurmountable peaks are not unlike the everyday trials that those living with Alzheimer’s disease and their caregivers face. Understanding personal limitations, reaching out for support and taking steps day by day are all challenges both climbers and caregivers experience. 

 

Many people are unaware of the enormous financial and personal burden placed on those with Alzheimer’s disease, their families and caregivers. The indirect and direct costs of caring for people with Alzheimer’s disease is estimated to be more than $100 billion a year in the United States alone. The worldwide costs of dementia are estimated to exceed one percent of global gross domestic product (GDP) in 2010, which equates to $600 billion, further demonstrating the global prevalence of the disease. And caring for a person with Alzheimer’s can be overwhelming, as research shows that caregivers themselves are often at an increased risk for depression and illness.

 

The Climbs

 

Alan’s world journey for Alzheimer’s disease involves climbing more than 45,000 meters all while enduring temperatures that may be 40 degrees below zero with winds as high as 50 mph. The summits Alan will climb are as follows:

  • Vinson, Antarctica – 16,067ft/4897m (Summitted: 12/9/2010)
  • Aconcagua, Argentina, South America – 22,841ft/6962m (Summitted: 1/29/2011)
  • Everest, Nepal, Asia – 29,035ft/8850m
  • Denali, Alaska, North America – 20,320ft/6194m
  • Elbrus, Russia, Europe – 18,481ft/5633m
  • Kilimanjaro, Tanzania, Africa – 19,340ft/5896m
  • Carstensz Pyramid, Indonesia, Oceania – 16,023ft/4884m

 

Alan is taking on the extended challenge of climbing an eighth summit, Mt. Kosciuszko in Australia, part of the Oceania continent.

 

The campaign website, www.Climb4AD.com, contains information about Alzheimer’s, the campaign and how you can follow Alan’s high-altitude climbs. You can also learn how you can help support Alan in raising funds for the organizations he has selected, the Cure Alzheimer’s FundTM for Alzheimer’s research and the National Family Caregivers Association to provide support for family caregivers. One hundred percent of any donation you give will go directly to the organization you choose.

About Alan

Alan Arnette, 54, lives in Colorado and was a caregiver for his mother, Ida Arnette, who suffered the symptoms of Alzheimer’s disease for nearly a decade until she died in 2009. Alan saw firsthand the urgent need for safe and effective treatments for Alzheimer’s disease, which currently has no cure. He also realized the support family caregivers need while caring for his own mother. Alan has combined his passion for mountaineering and his dedication to raising awareness of Alzheimer’s disease by embarking on the year-long journey. Alan is also striving to raise $1 million to advance Alzheimer’s research and provide support for family caregivers.

 

About the Campaign Supporters

Supporting Alan on this initiative, the Alzheimer’s Immunotherapy Program of Janssen Alzheimer Immunotherapy and Pfizer Inc., is funding Alan’s climbs so that all money he raises from donations will go directly to the organizations he has selected: the Cure Alzheimer’s FundTM to advance Alzheimer’s research and the National Family Caregivers Association to provide support for family caregivers.

 

Alzheimer’s Immunotherapy Program

The Alzheimer’s Immunotherapy Program of Janssen Alzheimer Immunotherapy and Pfizer Inc. is an equal collaboration committed to researching and developing selective products for the treatment and/or prevention of neurodegenerative conditions, including Alzheimer’s disease.

The Alzheimer’s Immunotherapy Program believes that it is possible to reduce the burden of disease through early intervention in the illness. It is dedicated to delivering comprehensive and integrated solutions that help address the needs of people impacted by Alzheimer’s disease.

Its research focuses on the beta amyloid hypothesis. Scientific evidence supports the idea that preventing the accumulation and/or promoting the removal of beta-amyloid may have the potential to slow the progression of Alzheimer’s disease and help preserve function in people with the disease. This theory is being tested in clinical trials.

 

Janssen Alzheimer Immunotherapy

Janssen Alzheimer Immunotherapy is researching, developing and commercializing selective products for the treatment and/or prevention of Alzheimer’s disease. Janssen Alzheimer Immunotherapy is based in Dublin and has R&D facilities in South San Francisco.

 

Pfizer Inc: Working together for a healthier world™

Pfizer applies science and global resources to improve health and well-being at every stage of life. The company strives to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. That includes a diversified global health care portfolio of human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with Pfizer’s responsibility as the world’s leading biopharmaceutical company, the corporation also collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for those in need. To learn more about Pfizer’s commitments, please visit www.pfizer.com

 

In addition to the Alzheimer’s Immunotherapy Program, other organizations supporting Alan’s efforts include:

 

Cure Alzheimer’s Fund

The Cure Alzheimer’s Fund is a non-profit public charity established to provide funding for targeted research into the causes of Alzheimer’s disease. The Cure Alzheimer’s Fund exists exclusively to fund targeted research to hasten the slowing, stopping or reversing of Alzheimer’s disease.

 

National Family Caregivers Association

National Family Caregivers Association envisions an America in which family caregivers lead full and productive lives, free from depression, pain, isolation and financial distress. NFCA provides family caregivers support, education and a public voice.

 

International Mountain Guides

Since 1986, International Mountain Guides, based in Ashford, WA has organized and led climbing, trekking and mountaineering expeditions around the world. International Mountain Guides is providing in-climb support.

Read Full Post »

National Family Caregivers Association Supports Advocate in His Mission to Raise Awareness of the Burden of Alzheimer’s Disease

SOUTH SAN FRANCISCO (February 3, 2011) – Janssen Alzheimer Immunotherapy, together with its collaborator on the Alzheimer’s Immunotherapy Program, Pfizer Inc., is pleased to announce the addition of the National Family Caregivers Association (NFCA), an organization that empowers family caregivers to act on behalf of themselves and their loved ones, as a supporter of The 7 Summits Climb for Alzheimer’s: Memories are Everything campaign.  NFCA joins the campaign just as alpine mountaineer and Alzheimer’s disease advocate Alan Arnette successfully summitted Aconcagua in Argentina, his second climb of the 7 Summits.  Through this campaign, Alan is seeking to climb the 7 Summits, the highest peak on each continent, in order to help raise awareness of the enormous financial and personal burden Alzheimer’s places on people with the disease, their family caregivers and society.  In addition, he hopes to raise $1 million.  The funds he raises will go directly to the Cure Alzheimer’s Fund™, and now NFCA to advance Alzheimer’s research and support for family caregivers, respectively.  It is estimated that more than 5 million Americans have Alzheimer’s and approximately 10.9 million unpaid caregivers see to their daily needs.

“The NFCA’s participation in this campaign spotlights the vital and expanding role of the Alzheimer’s caregiver, which is why we are so glad they have joined this effort,” said Stef Heylen, MD, Chief Medical Officer and Head of Research and Development for Janssen Alzheimer Immunotherapy, on behalf of the Alzheimer’s Immunotherapy Program.  “Through their participation in the 7 Summits campaign, NFCA will be able to reach even more family caregivers, providing education, support and a public voice.”

Prior to Aconcagua, Alan summitted the first of the 7 Summits — Mt. Vinson Massif, the highest peak in Antarctica — in December.  Coming up in April, Alan is planning to summit Mount Everest, the highest peak in the world.  The Alzheimer’s Immunotherapy Program of Janssen Alzheimer Immunotherapy and Pfizer Inc. is funding Alan’s climbs so that all money he raises from donations will go directly to the organizations he has selected.  You can track Alan’s progress or make a donation to one of his chosen charities by visiting www.Climb4AD.com or www.Facebook.com/Climb4AD.

“2011 marks the Year of the Caregiver, and as such, we are thrilled to join Alan in his efforts to raise awareness about Alzheimer’s and the burden it places on family caregivers,” said Suzanne Mintz, president and CEO of NFCA.  “We applaud Alan for his commitment, perseverance and tireless advocating for the AD community.”

Alzheimer’s disease is the sixth leading cause of death in the United States, with another person newly diagnosed every 70 seconds.  The burden of caring for these patients often falls to family members.  Last year, these family caregivers provided about 12.5 billion hours of unpaid care.

 

Alzheimer’s Immunotherapy Program

The Alzheimer’s Immunotherapy Program of Janssen Alzheimer Immunotherapy and Pfizer Inc. is an equal collaboration committed to researching and developing selective products for the treatment and/or prevention of neurodegenerative conditions, including Alzheimer’s disease.

The Alzheimer’s Immunotherapy Program believes that it is possible to reduce the burden of disease through early intervention in the illness.  It is dedicated to delivering comprehensive and integrated solutions that help address the needs of people impacted by Alzheimer’s disease.

Its research focuses on the beta amyloid hypothesis.  Scientific evidence supports the idea that preventing the accumulation and/or promoting the removal of beta-amyloid may have the potential to slow the progression of Alzheimer’s disease and help preserve function in people with the disease.  This theory is being tested in clinical trials.

Janssen Alzheimer Immunotherapy

Janssen Alzheimer Immunotherapy is researching, developing and commercializing selective products for the treatment and/or prevention of Alzheimer’s disease.  Janssen Alzheimer Immunotherapy is based in Dublin and has R&D facilities in South San Francisco.  http://www.janimm.com/

 

National Family Caregivers Association

National Family Caregivers Association (NFCA) envisions an America in which family caregivers lead full and productive lives, free from depression, pain, isolation, and financial distress.  NFCA provides family caregivers support, education, and a public voice.   www.nfcacares.org/

Cure Alzheimer’s Fund

The Cure Alzheimer’s Fund is a non-profit public charity established to provide funding for targeted research into the causes of Alzheimer’s disease.  The Cure Alzheimer’s Fund exists exclusively to fund targeted research to hasten the slowing, stopping or reversing of Alzheimer’s disease.   www.curealzfund.org/

Read Full Post »

Follow

Get every new post delivered to your Inbox.

Join 2,761 other followers

%d bloggers like this: